関連する実験動画
Updated: Feb 23, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.8K
DNMT2は,5'tiRNAGly-GCCの産生をダウンレギュレーションすることによって,アナプラスティック甲状腺がんの進行を抑制する
Ruixin Zhou1,2, Baizhao Li1,2, Mingyu Cao1,2
1Department of General Surgery, Xiangya Hospital of Central South University, Changsha, Hunan, China.
Cell death & disease
|February 21, 2026
まとめ
減少したDNAメチルトランスフェラーゼ2 (DNMT2) 発現は,5'tiRNAGly-GCCを増加させることで,アナプラスティック甲状腺癌 (ATC) を促進する. この分子は hnRNPH1 を標的とし,腫瘍の進行を促します. 5'tiRNAGly-GCCを阻害することは,ATCの治療の可能性を示しています.
科学分野:
- 分子生物学は分子生物学である.
- がん研究 がん研究
- エピジェネティクス エピジェネティクス
背景:
- 転送RNA (tRNA) の改変は,細胞の機能と完全性にとって極めて重要です.
- DNAメチルトランスフェラーゼ2 (DNMT2) は,tRNA m5Cメチル化に作用し,がんの進行に影響を与えます.
- DNMT2,tRNAメチル化,および腫瘍の発達を結びつける特定のメカニズムは完全に理解されていません.
研究 の 目的:
- アナプラスティック甲状腺がん (ATC) の進行におけるDNMT2の役割を調査する.
- TRNAメチル化によるDNMT2が腫瘍発育に影響を与える分子メカニズムを解明する.
- ATC治療のための潜在的な治療目標を特定する.
主な方法:
- ATCにおけるDNMT2表現の分析.
- 特定のtRNA (tRNA-Asp-GUC,tRNA-Gly-GCC,tRNA-Val-AAC) 上のDNMT2媒介のm5Cメチレーションサイトを特定する.
- 5'tiRNAGly-GCCの生成とそのhNRNPH1.1との相互作用を調査する.
- 5'tiRNAGly-GCC阻害剤とドクソルビシン塩化水素を用いたインビボ試験.
主要な成果:
- 減少したDNMT2発現はATC進行を促進することが判明しました.
- DNMT2は,ATCにおける特定のtRNAに対するm5C38メチレーションを触媒化する.
- DNMT2の損失は,ANG媒介の割れ方による5'tiRNAGly-GCCの豊富な増加につながります.
- 5'tiRNAGly-GCCはhnRNPH1と結合し,そのタンパク質レベルを低下させます.
- 5'tiRNAGly-GCCとドクソルビシン塩化水素の結合阻害は,ATCの進行を vivo で抑制しました.
結論:
- 減少したDNMT2発現は,5'tiRNAGly-GCCの産生を促進することによって,ATCの発達を促進する.
- 5'tiRNAGly-GCC/hnRNPH1軸は,ATC進行における重要なメカニズムである.
- 5'tiRNAGly-GCCをターゲットにすることは,ATCの有望な治療戦略です.
関連する概念動画
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
The Nucleolus
10.5K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.5K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
MicroRNAs
4.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K

